Mayo Clinic
Virend Somers, MD, PhD
The purpose of this study is to validate the LabClasp's ability to estimate blood \[lactate\].
Healthy
LabClasp
NA
Study Type : | INTERVENTIONAL |
Estimated Enrollment : | 50 participants |
Masking : | NONE |
Primary Purpose : | DIAGNOSTIC |
Official Title : | Validation of a Non-Invasive Instrument to Estimate Blood Lactate |
Actual Study Start Date : | 2025-02 |
Estimated Primary Completion Date : | 2025-09 |
Estimated Study Completion Date : | 2025-12 |
Information not available for Arms and Intervention/treatment
Ages Eligible for Study: | 18 Years |
Sexes Eligible for Study: | ALL |
Accepts Healthy Volunteers: | 1 |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Not yet recruiting
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905